Cramer Gives His Opinion On GlaxoSmithKline, Asana And More

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Penn National Gaming, Inc. PENN has been crushed, but selling the stock right now is a mistake.

With GlaxoSmithKline plc GSK having a 5% yield, Cramer believes it's "okay to own" the stock.

The "Mad Money" host said Asana, Inc. ASAN is too expensive versus salesforce.com, inc. CRM. He recommended owning Salesforce and not Asana.

Cramer said he likes Doximity, Inc. DOCS.

"They’re very expensive stocks. We’re closer to a bottom than we were a week ago," he added.

When asked about TG Therapeutics, Inc. TGTX, Cramer said "actually nothing is really wrong." However, the stock got some price target cuts and also made a couple of mistakes.